Get started
Author

Kaivalya Megha

ORCID: 0000-0003-4189-0866
Observed ORCID: 0000-0003-4189-0866
OpenAlex ID: A5003669043
Anti-Androgenic Therapies Targeting the Luminal Androgen Receptor of a Typical Triple-Negative Breast Cancer
2022 · Avinash Khadela, Vivek P. Chavda, et al. · Cancers · 24
PDF
Unveiling the antibody–drug conjugates portfolio in battling Triple-negative breast cancer: Therapeutic trends and Future horizon
2022 · Avinash Khadela, Shruti Soni, et al. · Medical Oncology · 18
Contracting triple-negative breast cancer with immunotherapeutic armamentarium: recent advances and clinical prospects
2022 · Avinash Khadela, Shruti Soni, et al. · Medical Oncology · 16
PDF
Exploring the Potential of Antibody-Drug Conjugates in Targeting Non-small Cell Lung Cancer Biomarkers
2024 · Avinash Khadela, Kaivalya Megha, et al. · Clinical Medicine Insights Oncology · 12
A Review on the Impact of the SARS-CoV-2 Omicron Subvariant on Elderly Patients with Diverse Co-Morbidities
2023 · Avinash Khadela, Shruti Soni, et al. · Biologics · 9
PDF
Unlocking the therapeutic potential of antibody–drug conjugates in targeting molecular biomarkers in non-small cell lung cancer
2025 · Shruti Soni, Kaivalya Megha, et al. · Journal of the Egyptian National Cancer Institute · 8
Treatment challenges in developing nations for patients with locally advanced or metastatic head-and-neck cancer
2023 · Avinash Khadela, Shruti Soni, et al. · Cancer Research Statistics and Treatment · 3
Works count: 7
Citation count: 90
H-index: 6
I10-index: 4
Year
Topic
Type